Lomitapide
CAS No. 182431-12-5
Lomitapide( AEGR-733 | BMS-201038 )
Catalog No. M17390 CAS No. 182431-12-5
Lomitapide is a small molecule inhibitor of microsomal triglyceride transfer protein (MTP), an enzyme located in the lumen of the endoplasmic reticulum responsible for absorbing dietary lipids and transferring triglycerides onto apolipoprotein B (apo-B) in the assembly of very-low-density lipoprotein.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 53 | In Stock |
|
| 5MG | 86 | In Stock |
|
| 10MG | 133 | In Stock |
|
| 25MG | 219 | In Stock |
|
| 50MG | 314 | In Stock |
|
| 100MG | 473 | In Stock |
|
| 200MG | 679 | In Stock |
|
| 500MG | 1044 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLomitapide
-
NoteResearch use only, not for human use.
-
Brief DescriptionLomitapide is a small molecule inhibitor of microsomal triglyceride transfer protein (MTP), an enzyme located in the lumen of the endoplasmic reticulum responsible for absorbing dietary lipids and transferring triglycerides onto apolipoprotein B (apo-B) in the assembly of very-low-density lipoprotein.
-
DescriptionLomitapide is a small molecule inhibitor of microsomal triglyceride transfer protein (MTP), an enzyme located in the lumen of the endoplasmic reticulum responsible for absorbing dietary lipids and transferring triglycerides onto apolipoprotein B (apo-B) in the assembly of very-low-density lipoprotein.
-
In Vitro——
-
In Vivo——
-
SynonymsAEGR-733 | BMS-201038
-
PathwayPI3K/Akt/mTOR signaling
-
TargetS6 Kinase
-
RecptorMTP
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number182431-12-5
-
Formula Weight692.71
-
Molecular FormulaC39H37F6N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 35 mg/mL; 50.45 mM
-
SMILESc1cccc2c1C(c1c2cccc1)(CCCCN1CCC(CC1)NC(=O)c1c(cccc1)c1ccc(cc1)C(F)(F)F)C(=O)NCC(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Davis KA, Miyares MA. Am J Health Syst Pharm. 2014 Jun 15;71(12):1001-8.
molnova catalog
related products
-
FMK
FMK is an irreversible inhibitor of RSK2 kinase.
-
PF-4708671
PF-4708671 is a cell-permeable inhibitor of p70 ribosomal S6 kinase (S6K1 isoform) with Ki/IC50 of 20 nM/160 nM in cell-free assays.
-
MBM-55S
MBM-55S effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis. MBM-55S shows antitumor activities, and no obvious toxicity to mice.
Cart
sales@molnova.com